1. Home
  2. HSDT vs VERO Comparison

HSDT vs VERO Comparison

Compare HSDT & VERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSDT
  • VERO
  • Stock Information
  • Founded
  • HSDT N/A
  • VERO N/A
  • Country
  • HSDT United States
  • VERO Canada
  • Employees
  • HSDT N/A
  • VERO N/A
  • Industry
  • HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • VERO Medical/Dental Instruments
  • Sector
  • HSDT Health Care
  • VERO Health Care
  • Exchange
  • HSDT Nasdaq
  • VERO Nasdaq
  • Market Cap
  • HSDT 2.5M
  • VERO 2.2M
  • IPO Year
  • HSDT N/A
  • VERO N/A
  • Fundamental
  • Price
  • HSDT $1.09
  • VERO $3.18
  • Analyst Decision
  • HSDT Hold
  • VERO
  • Analyst Count
  • HSDT 1
  • VERO 0
  • Target Price
  • HSDT N/A
  • VERO N/A
  • AVG Volume (30 Days)
  • HSDT 2.2M
  • VERO 3.1M
  • Earning Date
  • HSDT 05-01-2025
  • VERO 05-15-2025
  • Dividend Yield
  • HSDT N/A
  • VERO N/A
  • EPS Growth
  • HSDT N/A
  • VERO N/A
  • EPS
  • HSDT N/A
  • VERO N/A
  • Revenue
  • HSDT $434,000.00
  • VERO $60,997,000.00
  • Revenue This Year
  • HSDT $0.04
  • VERO N/A
  • Revenue Next Year
  • HSDT $75.10
  • VERO $7.47
  • P/E Ratio
  • HSDT N/A
  • VERO N/A
  • Revenue Growth
  • HSDT N/A
  • VERO N/A
  • 52 Week Low
  • HSDT $0.80
  • VERO $2.10
  • 52 Week High
  • HSDT $24.00
  • VERO $17.49
  • Technical
  • Relative Strength Index (RSI)
  • HSDT 21.24
  • VERO 65.91
  • Support Level
  • HSDT $0.80
  • VERO $2.31
  • Resistance Level
  • HSDT $4.10
  • VERO $2.49
  • Average True Range (ATR)
  • HSDT 0.49
  • VERO 0.24
  • MACD
  • HSDT -0.28
  • VERO 0.09
  • Stochastic Oscillator
  • HSDT 6.61
  • VERO 50.00

About HSDT Helius Medical Technologies Inc. (DE)

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS) is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.

About VERO Venus Concept Inc.

Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.

Share on Social Networks: